Partner David Rosen was quoted in a Korea Biomedical Review article, “How Korean pharma companies can succeed in US,” about how Korean pharmaceutical and biosimilar companies can find success in America.
Rosen, speaking at BIO KOREA 2019, said it is essential for Korean companies to develop drugs with a sense of responsibility for making the products safe. He also said if such expectations are not met, the companies can receive sanctions and penalties, including regulatory enforcement action, civil monetary penalties, and criminal liability.
“Import detention is something that everyone should be afraid the most as the Food and Drug Administration can block any import of the product,” he said. “Therefore, companies have to respond to all warning letters and the concerns that the FDA has, and address them.”
Rosen, speaking at BIO KOREA 2019, said it is essential for Korean companies to develop drugs with a sense of responsibility for making the products safe. He also said if such expectations are not met, the companies can receive sanctions and penalties, including regulatory enforcement action, civil monetary penalties, and criminal liability.
“Import detention is something that everyone should be afraid the most as the Food and Drug Administration can block any import of the product,” he said. “Therefore, companies have to respond to all warning letters and the concerns that the FDA has, and address them.”
People
Related News
08 May 2024
In the News
Foley Real Estate, Hospitality Transactions Highlighted in Golf Inc.
Foley & Lardner LLP served as legal advisor on two of Golf Inc.’s Top 10 Sales of 2023.
08 May 2024
In the News
Donald Schroeder Assesses Slimmed, Efficient Juries in Massachusetts Civil Trials
Foley & Lardner LLP partner Donald Schroeder assessed the increased efficiency of Massachusetts’ state civil courts as smaller juries remain in fashion even following the lapse of pandemic-era limitations
03 May 2024
In the News
Jeff Symons’ Move to Foley Featured in Press
Foley & Lardner LLP partner Jeff Symons is featured in legal press for his recent arrival to the firm